|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hammerschmidt M, Brook A and McMahon AP:
The world according to hedgehog. Trends Genet. 13:14–21. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee Y, Miller HL, Russell HR, Boyd K,
Curran T and McKinnon PJ: Patched2 modulates tumori-geneis in
patched1 heterozygous mice. Cancer Res. 66:6964–6971. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McMahon AP: More surprises in the Hedgehog
signaling pathway. Cell. 100:185–188. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li GL, Chen WQ, Wang QS, Ma AW and An R:
Analysis of the association between pancreas cancer and diabetes. J
Cancer Control Treat. 23:132–136. 2010.(In Chinese).
|
|
7
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tao YJ, Mao J, Zhang QQ and Li LH:
Hedgehog signaling pathway is activated in breast cancer
CD44+ CD24 cells. Shandong Med. 51:33–35. 2011.(In
Chinese).
|
|
9
|
Lee CJ, Dosch J and Simeone DM: Pancreatic
cancer stem cells. J Clin Oncol. 26:2806–2812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mimeault M and Batra SK: Frequent
deregulations in the hedgehog signaling network and cross-talks
with the epidermal growth factor receptor pathway involved in
cancer progression andt argeted therapies. Pharmacol Rev.
62:497–524. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Berman DM, Karhadkar SS, Maitra A, Montes
De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman
JR, Watkins DN and Beachy PA: Widespread requirement for Hedgehog
ligand stimulation in growth of digestive tract tumours. Nature.
425:846–851. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thayer SP, di Magliano MP, Heiser PW,
Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernández-del
Castillo C, Yajnik V, et al: Hedgehog is an early and late mediator
of pancreatic cancer tumorigenesis. Nature. 425:851–856. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang K and Jia J: Smoothened regulation
in response to Hedgehog stimulation. Front Biol (Beijing).
10:475–486. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang L, Xie G, Fan Q and Xie J: Activation
of the hedgehog-signaling pathway in human cancer and the clinical
implications. Oncogene. 29:469–481. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sekulic A, Migden MR, Oro AE, Dirix L,
Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander
PA, et al: Efficacy and safety of vismodegib in advanced basal-cell
carcinoma. N Engl J Med. 366:2171–2179. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Atwood SX, Sarin KY, Whitson RJ, Li JR,
Kim G, Rezaee M, Ally MS, Kim J, Yao C, Chang AL, et al: Smoothened
variants explain the majority of drug resistance in basal cell
carcinoma. Cancer Cell. 27:342–353. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Patel R, Ede J, Collins J and David
Willens: Pancreatic cancer presenting as new-onset diabetes. Case
Rep Oncol. 7:171–174. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tong GX, Geng QQ, Chai J, Cheng J, Chen
PL, Liang H, Shen XR and Wang DB: Association between pancreatitis
and subsequent risk of pancreatic cancer: A systematic review of
epidemiological studies. Asian Pac J Cancer Prev. 15:5029–5034.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li C, Heidt DG, Dalerba P, Burant CF,
Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification
of pancreatic cancer stem cells. Cancer Res. 67:1030–1037. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Farhana L, Dawson MI, Das JK, Murshed F,
Xia Z, Hadden TJ, Hatfield J and Fontana JA: Adamantyl
retinoid-related molecules induce apoptosis in pancreatic cancer
cells by inhibiting IGF-1R and Wnt/β-catenin pathways. J Oncol.
2012:7967292012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yao J, An Y, Qian JJ, Bai DS, Xu ZK and
Miao Y: Hedgehog signaling pathway inhibitor reverts acquired
chemoresistance in human pancreatic cancer SWl990 cell line. Chin J
Pancreatol. 184–188. 2012.
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lizée G, Aerts JL, Gonzales MI, Chinnasamy
N, Morgan RA and Topalian SL: Real-time quantitative reverse
transcriptase-polymerase chain reaction as a method for determining
lentiviral vector titers and measuring transgene expression. Hum
Gene Ther. 14:497–507. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fu J, Rodova M, Roy SK, Sharma J, Singh
KP, Srivastava RK and Shankar S: GANT-61 inhibits pancreatic cancer
stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice
xenograft. Cancer Lett. 330:22–32. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Clement V, Sanchez P, de Tribolet N,
Radovanovic I and Ruiz i Altaba A: HEDEGHOG-GLI1 signaling
regulates human glioma growth, cancer stem cell self-renewal, and
tumorigenicity. Curr Biol. 17:165–172. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Kong D, Ahmad A, Bao B and Sarkar
FH: Pancreatic cancer stem cells: Emerging target for designing
novel therapy. Cancer Lett. 338:94–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Onishi H, Morifuji Y, Kai M, Suyama K,
Iwasaki H and Katano M: Hedgehog inhibitor decreases
chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic
conditions in pancreatic cancer. Cancer Sci. 103:1272–1279. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hao K, Tian XD, Qin CF, Xie XH and Yang
YM: Hedgehog signaling pathway regulates human pancreatic cancer
cell proliferation and metastasis. Oncol Rep. 29:1124–1132. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang H, Li Q, He C, Li F, Sheng H, Shen
X, Zhang X, Zhu S, Chen H, Chen X, et al: Activation of the Wnt
pathway through Wnt2 promotes metastasis in pancreatic cancer. Am J
Cancer Res. 4:537–544. 2014.PubMed/NCBI
|
|
30
|
Fujihira A, Suzuki T, Chang MO, Moriyama
T, Kitajima M and Takaku H: Antitumor effects of
baculovirus-infected dendritic cells against human pancreatic
carcinoma. Gene Ther. 21:849–854. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu R, Li F, Zhu J, Tang R, Qi Q, Zhou X,
Li R, Wang W, Hua D and Chen W: A functional variant at miR-132-3p,
miR-212-3p, and miR-361-5p binding site in CD80 gene
alterssusceptibility to gastric cancer in a Chinese Han population.
Med Oncol. 31:602014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tuschl T: Expanding small RNA
interference. Nat Biotechnol. 20:446–448. 2002. View Article : Google Scholar : PubMed/NCBI
|
